James P. Mitchum
CIK 1597439 · last filed 2021-06-15
James P. Mitchum is a corporate insider who has filed 6 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for TENX, was dated Jun 15, 2021. Across all open-market trades the lifetime net is +$50.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $516.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$516.6K
2
6
$50.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TENX | Director | 45,000 | $11.48 | $516.6K | $50.5K | 5 | 2021-06-15 |
| NephroGenex, Inc. (NRX) Delisted | Director | — | — | — | $0 | 1 | 2015-05-04 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-15 | TENX | Grant (A) | — | $0 | EDGAR |
| 2020-05-15 | TENX | Grant (A) | — | $0 | EDGAR |
| 2019-04-18 | TENX | Grant (A) | — | $0 | EDGAR |
| 2016-11-22 | TENX | Disp (D) | +7,000 | $10.6K | EDGAR |
| 2016-02-19 | TENX | Buy (P) | +19,000 | $50.5K | EDGAR |
| 2015-05-04 | NephroGenex, Inc. (NRX) Delisted | Grant (A) | — | $0 | EDGAR |